Dermata Total Current Liabilities vs Common Stock Shares Outstanding Analysis

DRMAW Stock

USD 0.01 0.00 0.00%

Dermata Therapeutics financial indicator trend analysis is much more than just examining Dermata Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dermata Therapeutics is a good investment. Please check the relationship between Dermata Therapeutics Total Current Liabilities and its Common Stock Shares Outstanding accounts. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Current Liabilities vs Common Stock Shares Outstanding

Total Current Liabilities vs Common Stock Shares Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dermata Therapeutics Total Current Liabilities account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Dermata Therapeutics' Total Current Liabilities and Common Stock Shares Outstanding is -0.01. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Dermata Therapeutics Warrant, assuming nothing else is changed. The correlation between historical values of Dermata Therapeutics' Total Current Liabilities and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Dermata Therapeutics Warrant are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Total Current Liabilities i.e., Dermata Therapeutics' Total Current Liabilities and Common Stock Shares Outstanding go up and down completely randomly.

Correlation Coefficient

-0.01

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Dermata Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Dermata Therapeutics Warrant are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most indicators from Dermata Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dermata Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Issuance Of Capital Stock is likely to climb to about 6.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 3.5 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	45.6K	63.6K	57.2K	111.4K
Depreciation And Amortization	14.1K	9.7K	8.0M	8.4M

Interest Expense Depreciation And Amortization

Dermata Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Non Currrent Assets Other
Total Assets		0.73	0.8	-0.44	0.95	-0.41	-0.98	-0.74	0.76	1.0	0.71	-0.41	1.0	-0.32	0.47	0.97	0.42	-0.74	1.0	-0.41	0.72	1.0	0.99	0.72	-0.93	-0.41
Short Long Term Debt Total	0.73		0.25	0.14	0.78	-0.39	-0.64	-0.77	0.54	0.72	0.38	-0.39	0.72	-0.32	0.49	0.81	0.9	-0.28	0.76	-0.39	1.0	0.73	0.64	1.0	-0.82	-0.39
Other Current Liab	0.8	0.25		-0.58	0.65	-0.29	-0.83	-0.39	0.71	0.82	0.72	-0.29	0.82	-0.38	0.35	0.64	-0.09	-0.66	0.77	-0.29	0.24	0.8	0.83	0.24	-0.59	-0.29
Total Current Liabilities	-0.44	0.14	-0.58		-0.44	0.14	0.57	0.28	-0.56	-0.45	-0.12	0.14	-0.45	-0.01	-0.13	-0.4	0.47	0.91	-0.41	0.14	0.15	-0.44	-0.58	0.15	0.39	0.14
Total Stockholder Equity	0.95	0.78	0.65	-0.44		-0.59	-0.96	-0.9	0.79	0.95	0.49	-0.59	0.95	-0.42	0.63	0.97	0.55	-0.77	0.96	-0.59	0.78	0.95	0.93	0.78	-1.0	-0.59
Current Deferred Revenue	-0.41	-0.39	-0.29	0.14	-0.59		0.5	0.82	-0.55	-0.41	0.1	1.0	-0.41	0.89	-0.95	-0.4	-0.47	0.33	-0.4	1.0	-0.37	-0.41	-0.36	-0.37	0.61	1.0
Net Debt	-0.98	-0.64	-0.83	0.57	-0.96	0.5		0.77	-0.81	-0.98	-0.63	0.5	-0.98	0.39	-0.54	-0.94	-0.33	0.82	-0.97	0.5	-0.63	-0.98	-0.99	-0.63	0.93	0.5
Retained Earnings	-0.74	-0.77	-0.39	0.28	-0.9	0.82	0.77		-0.77	-0.73	-0.11	0.82	-0.73	0.65	-0.86	-0.79	-0.67	0.61	-0.75	0.82	-0.76	-0.74	-0.7	-0.76	0.92	0.82
Accounts Payable	0.76	0.54	0.71	-0.56	0.79	-0.55	-0.81	-0.77		0.77	0.2	-0.55	0.77	-0.6	0.72	0.7	0.24	-0.75	0.73	-0.55	0.52	0.76	0.79	0.52	-0.78	-0.55
Cash	1.0	0.72	0.82	-0.45	0.95	-0.41	-0.98	-0.73	0.77		0.71	-0.41	1.0	-0.33	0.47	0.96	0.41	-0.74	1.0	-0.41	0.71	1.0	0.99	0.71	-0.92	-0.41
Non Current Assets Total	0.71	0.38	0.72	-0.12	0.49	0.1	-0.63	-0.11	0.2	0.71		0.1	0.71	0.07	-0.11	0.62	0.14	-0.28	0.71	0.1	0.38	0.71	0.68	0.38	-0.44	0.1
Long Term Debt	-0.41	-0.39	-0.29	0.14	-0.59	1.0	0.5	0.82	-0.55	-0.41	0.1		-0.41	0.89	-0.95	-0.4	-0.47	0.33	-0.4	1.0	-0.37	-0.41	-0.36	-0.37	0.61	1.0
Cash And Short Term Investments	1.0	0.72	0.82	-0.45	0.95	-0.41	-0.98	-0.73	0.77	1.0	0.71	-0.41		-0.33	0.47	0.96	0.41	-0.74	1.0	-0.41	0.71	1.0	0.99	0.71	-0.92	-0.41
Common Stock Shares Outstanding	-0.32	-0.32	-0.38	-0.01	-0.42	0.89	0.39	0.65	-0.6	-0.33	0.07	0.89	-0.33		-0.94	-0.23	-0.37	0.13	-0.3	0.89	-0.29	-0.32	-0.26	-0.29	0.44	0.89
Non Current Liabilities Total	0.47	0.49	0.35	-0.13	0.63	-0.95	-0.54	-0.86	0.72	0.47	-0.11	-0.95	0.47	-0.94		0.43	0.5	-0.35	0.45	-0.95	0.47	0.47	0.42	0.47	-0.65	-0.95
Other Current Assets	0.97	0.81	0.64	-0.4	0.97	-0.4	-0.94	-0.79	0.7	0.96	0.62	-0.4	0.96	-0.23	0.43		0.54	-0.74	0.98	-0.4	0.81	0.97	0.95	0.81	-0.96	-0.4
Other Stockholder Equity	0.42	0.9	-0.09	0.47	0.55	-0.47	-0.33	-0.67	0.24	0.41	0.14	-0.47	0.41	-0.37	0.5	0.54		0.06	0.47	-0.47	0.9	0.42	0.29	0.9	-0.6	-0.47
Total Liab	-0.74	-0.28	-0.66	0.91	-0.77	0.33	0.82	0.61	-0.75	-0.74	-0.28	0.33	-0.74	0.13	-0.35	-0.74	0.06		-0.72	0.33	-0.28	-0.74	-0.83	-0.28	0.74	0.33
Net Invested Capital	1.0	0.76	0.77	-0.41	0.96	-0.4	-0.97	-0.75	0.73	1.0	0.71	-0.4	1.0	-0.3	0.45	0.98	0.47	-0.72		-0.4	0.76	1.0	0.98	0.76	-0.94	-0.4
Property Plant And Equipment Gross	-0.41	-0.39	-0.29	0.14	-0.59	1.0	0.5	0.82	-0.55	-0.41	0.1	1.0	-0.41	0.89	-0.95	-0.4	-0.47	0.33	-0.4		-0.37	-0.41	-0.36	-0.37	0.61	1.0
Short Long Term Debt	0.72	1.0	0.24	0.15	0.78	-0.37	-0.63	-0.76	0.52	0.71	0.38	-0.37	0.71	-0.29	0.47	0.81	0.9	-0.28	0.76	-0.37		0.72	0.63	1.0	-0.81	-0.37
Total Current Assets	1.0	0.73	0.8	-0.44	0.95	-0.41	-0.98	-0.74	0.76	1.0	0.71	-0.41	1.0	-0.32	0.47	0.97	0.42	-0.74	1.0	-0.41	0.72		0.99	0.72	-0.93	-0.41
Net Working Capital	0.99	0.64	0.83	-0.58	0.93	-0.36	-0.99	-0.7	0.79	0.99	0.68	-0.36	0.99	-0.26	0.42	0.95	0.29	-0.83	0.98	-0.36	0.63	0.99		0.63	-0.9	-0.36
Short Term Debt	0.72	1.0	0.24	0.15	0.78	-0.37	-0.63	-0.76	0.52	0.71	0.38	-0.37	0.71	-0.29	0.47	0.81	0.9	-0.28	0.76	-0.37	1.0	0.72	0.63		-0.81	-0.37
Common Stock	-0.93	-0.82	-0.59	0.39	-1.0	0.61	0.93	0.92	-0.78	-0.92	-0.44	0.61	-0.92	0.44	-0.65	-0.96	-0.6	0.74	-0.94	0.61	-0.81	-0.93	-0.9	-0.81		0.61
Non Currrent Assets Other	-0.41	-0.39	-0.29	0.14	-0.59	1.0	0.5	0.82	-0.55	-0.41	0.1	1.0	-0.41	0.89	-0.95	-0.4	-0.47	0.33	-0.4	1.0	-0.37	-0.41	-0.36	-0.37	0.61

Click cells to compare fundamentals

Dermata Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Dermata Stock Analysis

When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dermata Total Current Liabilities vs Common Stock Shares Outstanding Analysis

Total Current Liabilities vs Common Stock Shares Outstanding

Total Current Liabilities vs Common Stock Shares Outstanding Correlation Analysis

Correlation Coefficient

Total Current Liabilities

Common Stock Shares Outstanding

Dermata Therapeutics fundamental ratios Correlations

Dermata Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Dermata Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Short Long Term Debt	+ 1.0	Short Long Term Debt Total
Short Term Debt	+ 1.0	Short Long Term Debt Total

Common Stock	- 1.0	Total Stockholder Equity
Net Working Capital	- 0.99	Net Debt
Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Net Debt	- 0.98	Total Assets